3-Bromopyruvate is known for glycolytic inhibitors. Potential target is hexoknase II and/or glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
|Catalog #||Material Name||Company Name||Solute/Solvent|
In vitro test:
Dissolve in distilled water to make a 0.5 M stock solution. Aliquote and store at -20 degree
1. Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells. Science. 2009; 325:1555. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, Schmidt K, Wilson JK, Markowitz S, Zhou S, Diaz LA Jr, Velculescu V, Lengauer C, Kinzler KW, Vogelstein B, Papadopoulos N.
|Eppendorf epMotion 5070|
|A perfect match for all liquid handling applications, such as serial dilutions, reagent distribution PCR/qPCR and sequencing setup.|
|High Throughput Applications|
|Silica membrane kits in flexible 8-well and 96-well formats, ultrafiltration and magnetic beads for all applications. Contact a specialist|
|Antibodies from Epitomics|
|Over 6800 high quality antibodies from Epitomics. All Epitomics antibodies are validated in WB, IHC, ICC/IF, IP and FACS. Learn more|